Melphalan exposure induces an interleukin-6 deficit in bone marrow stromal cells and osteoblasts

被引:10
|
作者
Rellick, Stephanie L. [2 ]
Piktel, Debbie [2 ]
Walton, Cheryl [2 ]
Hall, Brett [4 ]
Petros, William
Fortney, James E. [2 ]
Gencheva, Marieta
Denvir, Jim [5 ]
Hobbs, Gerald [5 ]
Craig, Michael
Gibson, Laura F. [1 ,2 ,3 ]
机构
[1] W Virginia Univ, Mary Babb Randolph Canc Ctr, Sch Med, Alexander B Osborn Hematopoiet Malignancy & Trans, Morgantown, WV 26506 USA
[2] W Virginia Univ, Canc Cell Biol Program, Morgantown, WV 26506 USA
[3] W Virginia Univ, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA
[4] Ohio State Univ, Coll Med, Columbus, OH 43210 USA
[5] W Virginia Univ, Dept Stat, Morgantown, WV 26506 USA
关键词
Interleukin-6; Melphalan; Bone marrow microenvironment; Osteoblast; Bone marrow stromal cell; HEMATOPOIETIC STEM-CELL; MULTIPLE-MYELOMA; GROWTH-FACTOR; EXPRESSION; ENDOTHELIUM; SECRETION; ADHESION; NICHES; LINES; MICE;
D O I
10.1016/j.cyto.2012.01.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bone marrow stromal cells (BMSC) and osteoblasts are critical components of the microenvironment that support hematopoietic recovery following bone marrow transplantation. Aggressive chemotherapy not only affects tumor cells, but also influences additional structural and functional components of the microenvironment. Successful reconstitution of hematopoiesis following stem cell or bone marrow transplantation after aggressive chemotherapy is dependent upon components of the microenvironment maintaining their supportive function. This includes secretion of soluble factors and expression of cellular adhesion molecules that impact on development of hematopoietic cells. In the current study, we investigated the effects of chemotherapy treatment on BMSC and human osteoblast (HOB) expression of interleukin-6 (IL-6) as one regulatory factor. IL-6 is a pleiotropic cytokine which has diverse effects on hematopoietic cell development. In the current study we demonstrate that exposure of BMSC or HOB to melphalan leads to decreases in IL-6 protein expression. Decreased IL-6 protein is the most pronounced following melphalan exposure compared to several other chemotherapeutic agents tested. We also observed that melphalan decreased IL-6 mRNA in both BMSC and HOB. Finally, using a model of BMSC or HOB co-cultured with myeloma cells exposed to melphalan, we observed that IL-6 protein was also decreased, consistent with treatment of adherent cells alone. Collectively, these observations are of dual significance. First, suggesting that chemotherapy induced IL-6 deficits in the bone marrow occur which may result in defective hematopoietic support of early progenitor cells. In contrast, the decrease in IL-6 protein may be a beneficial mechanism by which melphalan acts as a valuable therapeutic agent for treatment of multiple myeloma, where IL-6 present in the bone marrow acts as a proliferative factor and contributes to disease progression. Taken together, these data emphasize the responsiveness of the microenvironment to diverse stress that is important to consider in therapeutic settings. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:245 / 252
页数:8
相关论文
共 50 条
  • [31] Tri-iodothyronine regulates the production of interleukin-6 and interleukin-8 in human bone marrow stromal and osteoblast-like cells
    Siddiqi, A
    Burrin, JM
    Wood, DF
    Monson, JP
    JOURNAL OF ENDOCRINOLOGY, 1998, 157 (03) : 453 - 461
  • [32] PRODUCTION OF INTERLEUKIN-6 IN HUNAN OSTEOBLASTS AND HUMAN BONE-MARROW STROMAL CELLS - EVIDENCE THAT INDUCTION BY INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR-ALPHA IS NOT REGULATED BY OVARIAN-STEROIDS
    RIFAS, L
    KENNEY, JS
    MARCELLI, M
    PACIFICI, R
    CHENG, SL
    DAWSON, LL
    AVIOLI, LV
    ENDOCRINOLOGY, 1995, 136 (09) : 4056 - 4067
  • [33] TERMINAL DIFFERENTIATION OF HUMAN BONE-MARROW CELLS CAPABLE OF SPONTANEOUS AND HIGH-RATE IMMUNOGLOBULIN SECRETION - ROLE OF BONE-MARROW STROMAL CELLS AND INTERLEUKIN-6
    ROLDAN, E
    BRIEVA, JA
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (11) : 2671 - 2677
  • [34] Interleukin-6 induces glutathione in hippocampal cells
    Schmidt, AJ
    Krieg, JC
    Vedder, H
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2005, 29 (02): : 321 - 326
  • [35] Interleukin-6 signaling in osteoblasts regulates bone remodeling during exercise
    Palmisano, Biagio
    Riminucci, Mara
    Karsenty, Gerard
    BONE, 2023, 176
  • [36] Bone marrow stromal cells transduced with a thrombopoietin, interleukin-6, and interleukin-11 syncretic gene induce cord mononuclear cells to generate platelets in vitro
    Lu, Hua
    Jiang, Tianlun
    Li, Ruqing
    Wang, Shichun
    Zhang, Qiang
    Zhao, Shuming
    TRANSFUSION, 2015, 55 (01) : 176 - 186
  • [37] Lack of evidence for an increase in interleukin-6 expression in adult murine bone, bone marrow, and marrow stromal cell cultures after ovariectomy
    Vargas, SJ
    Naprta, A
    Lee, SK
    Kalinowski, J
    Kawaguchi, H
    Pilbeam, CC
    Raisz, LG
    Lorenzo, JA
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 (12) : 1926 - 1934
  • [38] Effect of interleukin-6 secreted by engineered human stromal cells on osteoclasts in human bone
    Sandhu, JS
    Gorczynski, RM
    Waddell, J
    Nguyen, H
    Squires, J
    Waddell, J
    Boynton, EL
    Hozumi, N
    BONE, 1999, 24 (03) : 217 - 227
  • [39] Microgravity induces prostaglandin E(2) and interleukin-6 production in normal rat osteoblasts: Role in bone demineralization
    Kumei, Y
    Shimokawa, H
    Katano, H
    Hara, E
    Akiyama, H
    Hirano, M
    Mukai, C
    Nagaoka, S
    Whitson, PA
    Sams, CF
    JOURNAL OF BIOTECHNOLOGY, 1996, 47 (2-3) : 313 - 324
  • [40] HGF accelerate RANKL expression in bone marrow stromal cells and osteoblasts
    Tabata, Mitsuki
    Tsubaki, Masanobu
    Takeda, Tomoya
    Kato, Natsuki
    Nishida, Shozo
    CANCER SCIENCE, 2018, 109 : 1278 - 1278